Expression of receptors for epidermal growth factor and insulin-like growth factor I by ZR-75-1 human breast cancer cell variants is inversely related: The effect of steroid hormones on insulin-like growth factor I receptor expression

British Journal of Cancer

Volumn 73, Issue 4, 1996, Pages 477-481

  Van Den Berg, H W ^a   Claffie, D ^a   Boylan, M ^a   McKillen, J ^a   Lynch, M ^a   McKibben, B ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Breast cancer; Epidermal growth factor receptor; Insulin like growth factor receptor; Steroid hormone

Indexed keywords

16ALPHA ETHYL 21 HYDROXY 19 NORPREGN 4 ENE 3,20 DIONE; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; GLUCOCORTICOID RECEPTOR; PROGESTERONE RECEPTOR; SOMATOMEDIN C RECEPTOR; STEROID HORMONE; STEROID RECEPTOR;

ARTICLE; BREAST CANCER; CELL LINE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL LINE; DEXAMETHASONE; ESTRADIOL; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KINETICS; PREGNENEDIONES; PROGESTERONE CONGENERS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, IGF TYPE 1; TUMOR CELLS, CULTURED;

EID: 0030041324     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.84     Document Type: Article

References (24)

1. ANDREATTA VAN LEYEN S, HEMBREE JR AND ECKERT RL. (1994). Regulation of insulin-like growth factor 1 binding protein 3 levels by epidermal growth factor and retinoic acid in cervical epithelial cells. J. Cell Physiol., 160, 265-274.
2. EWING TM, MURPHY LJ, NG ML, PANG GYN, LEE CSL, WATTS CKW AND SUTHERLAND RL. (1989). Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines. Int. J. Cancer, 44, 744-752.
3. FOEKENS JA, PORTENGEN H, VAN PUTTEN WLJ, TRAPMAN AMAC, REUBI JC, ALEXIEVA-FIGUSCH J AND KLIJN JGM. (1989). Prognostic value of receptors for insulin-like growth factor-I, somatostatin, and epidermal growth factor in human breast cancer. Cancer Res., 49, 7002-7009.
4. FRAKER PJ AND SPECK JC. (1978). Protein and cell membrane iodinations with a sparingly soluble chloramine, 1,3,4,6-tetrachloro-3a, 6a-diphenylglycoluril. Biochem. Biophys. Res. Commun., 80, 849-857.
5. HANA V AND MURPHY LJ. (1994). Interdependence of epidermal growth factor and insulin-like growth factor-I expression in the mouse uterus. Endocrinology, 135, 107-112.
6. HARRIS AL. (1989). Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interactions with Neu. J. Biochem., 34, 123-131.
7. HEMBREE JR, AGARWAL C AND ECKERT RL. (1994). Epidermal growth factor suppresses insulin-like growth factor binding protein 3 levels in human papillomavirus type 16-immortalized cervical epithelial cells and thereby potentiates the effects of insulin-like growth factor 1. Cancer Res., 54, 3160-3166.
8. KEIGHTLY DD AND CRESSIE NAC. (1980). The Woolf plot is more reliable than the Scatchard plot in analysing data from hormone receptor assays. J. Steroid Biochem., 13, 1317.
9. LAHTI EI, KNIP M AND LAATIKAINEN TJ. (1994). Plasma insulin-like growth factor I and its binding proteins 1 and 3 in postmenopausal patients with breast cancer receiving long term tamoxifen. Cancer, 74, 618-624.
10. LONG B, MCKIBBEN B, LYNCH M AND VAN DEN BERG HW. (1992). Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast cancer cell line. Br. J. Cancer, 65, 865-869.
11. LONNING PE. (1992). Influence of tamoxifen on plasma levels of insulin-like growth factor-I and insulin-like growth factor binding protein-I in breast cancer patients. Cancer Res., 52, 4719-4723.
12. MANNI A, BADGER B, WEI L, ZAENGLEIN A, GROVE R, KHIN S, HEITJAN D, SHIMASAKI S AND LING N. (1994). Hormonal regulation of insulin-like growth factor II and insulin-like growth factor binding protein expression by breast cancer cells in vivo: evidence for stromal epithelial interactions. Cancer Res., 54, 2934-2942.
13. NICHOLSON S. (1988). Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance. Int. J. Cancer. 42, 36-41.
14. OSBORNE CK, CORONADO EB, KITTEN LJ, ARTEAGA CI, FUQUA SAW, RAMASHARMA K, MARSHALL M AND LIT CH. (1989). Insulin-like growth factor-II (IGF-II) - a potential autocrine paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol. Endocrinol., 3, 1701-1709.
15. OWENS PC, GILL PG, DE YOUNG MA, WEGER MA, KNOWLES SE AND MOYSE KJ. (1993). Estrogen and progesterone regulate secretion of insulin-like growth factor binding proteins by human breast cancer. Biochem. Biophys. Res. Commun., 193, 467-473.
16. PAPA V, HARTMANN KKP, ROSENTHAL SM, MADDUX BA, SIITERI PK AND GOLDFINE ID. (1991). Progestins induce down-regulation of insulin-like growth, factor-I (IGF-I) receptors in human breast cancer cells - potential autocrine role of IGF-II. Mol. Endocrinol., 5, 709-717.
17. PEKONEN F, PARANEN S, MAKINEN T AND RUTANEN EM. (1988). Receptors for epidermal growth factor and insulin-like growth factor-I and their relation to steroid receptors in human breast cancer. Cancer Res., 48, 1343-1347.
18. POLLACK MN, HUYNH HT AND LEFEBVRE SP. (1992). Tamoxifen reduces serum insulin-like growth factor I (IGF-I). Breast Cancer Res. Treat., 22, 91-100.
19. RAILO MJ, SMITTEN KV AND PEKONEN F. (1994). The prognostic value of insulin-like growth factor-I in breast cancer patients. Results of a follow-up on 126 patients. Eur. J. Cancer, 30A, 307-311.
20. SCHAFFER L, LARSEN UD, LINDE S, HEJNAES KR AND SKRIVER L. (1993). Characterisation of the three 125-I-iodination isomers of human insulin-like growth factor I (IGF1). Biochim. Biophys. Acta, 1203, 205-209.
21. STEWART AJ, JOHNSON MD, MAY FEB AND WESTLEY BR. (1990). Role of insulin-like growth factor receptors in the estrogen stimulated proliferation of human breast cancer cells. J. Biol. Chem., 265, 21172-21178.
22. VAN DEN BERG HW, LYNCH M, MARTIN JHJ, NELSON J, DICKSON GR AND CROCKARD AD. (1989). Characterisation of a tamoxifen resistant variant of the ZR-75-1 human breast cancer cell line, ZR-75-9a1 and stability of the resistant phenotype. Br. J. Cancer, 59, 522-526.
23. VAN DEN BERG HW, MARTIN JHJ AND LYNCH M. (1990). High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions. Br. J. Cancer, 61, 504-507.
24. VAN DEN BERG HW, LYNCH M AND MARTIN JHJ. (1993). The relationship between affinity of progestins and antiprogestins for the progesterone receptor in breast cancer cells (ZR-PR-LT) and the ability to down-regulate the receptor: evidence for heterospecific receptor modulation via the glucocorticoid receptor. Eur. J. Cancer, 29A, 1771-1775.